mRNA |
dacarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.0079 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
Obatoclax Mesylate |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
BRD-K99006945 |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
BRD-K13185470 |
CTRPv2 |
pan-cancer |
AAC |
-0.017 |
0.8 |
mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.076 |
0.8 |
mRNA |
RAF265 |
CTRPv2 |
pan-cancer |
AAC |
-0.0097 |
0.8 |
mRNA |
masitinib |
CTRPv2 |
pan-cancer |
AAC |
0.0085 |
0.8 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.8 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0078 |
0.8 |